Last reviewed · How we verify
NCT06252012
The Effect of Cervical Cancer Awareness Education Based on Mobile Application
NA trial testing Mobile application in Cervix Cancer in 120 participants. Completed in 27 May 2025.
21 October 2024
Quick facts
| Lead sponsor | Kutahya Health Sciences University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 120 |
| Start date | 1 April 2024 |
| Primary completion | 21 October 2024 |
| Estimated completion | 27 May 2025 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Mobile application
Conditions studied
- Cervix Cancer — all drugs for Cervix Cancer →
- Cancer Awareness — all drugs for Cancer Awareness →
- Mobile Application — all drugs for Mobile Application →
- HPV — all drugs for HPV →
Sponsor
Kutahya Health Sciences University
Who can join
Adults 35 to 60, female only, with Cervix Cancer or Cancer Awareness. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Cervical cancer is one of the most common cancer types affecting women in our country and in the world and causing morbidity. However, the availability of a vaccine for cervical cancer, preventable risk factors and early diagnosis tests offer a unique opportunity to reduce the rate of cervical cancer. In this context, there are studies showing that the practices developed by policies differ and that the classical health approach is insufficient. The effectiveness of the trainings given may vary according to time, place, trainer and personal characteristics of the individual. At the same time, in order to improve the attitudes and behaviours of individuals in terms of prevention and early diagnosis of cervical cancer, awareness of individuals about cervical cancer should be increased. In this way, women will have a say about their own health and their conscious participation in health care services will be realised. Therefore, the aim of this project is to apply cervical cancer awareness training to women and to examine its effect on women's cervical cancer prevention and early diagnosis behaviours. Original value; The fact that there is no mobile application developed for cervical cancer in Turkey reveals the national value of the research. In addition, the mobile application has international unique value as it is the first mobile application structured to provide awareness on cervical cancer prevention and early diagnosis behaviours. The project method was planned for the development and implementation of the mobile application programme. The research design will be a randomised controlled study. The 120 women who meet the inclusion criteria and who apply to more than one family health centre will be randomly assigned to the intervention and control groups. The effect of the mobile application programme on women's attitudes and behaviours towards cervical cancer prevention and early diagnosis will be evaluated at the 6th and 12th weeks. In the evaluation of the data, t-test for independent groups, anova and chi-square tests will be used to measure the effect of the intervention. Widespread effect; In this way, it is planned to reduce the time spent by professionals for care-related activities, to strengthen time management, to provide advantages and improvements in the performance of nurses in patient care management by using technological resources in the health care provided.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06252012
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Mobile application
Trials testing the same drug.
- NCT07489261 — Effect of Mobile Application- and AI Supported Video-Based Patient Education on Patient Outcomes in Teaching Clean Inter · NA · not yet recruiting
- NCT07371364 — Mobile Application for Women With Polycystic Ovary Syndrome · NA · active not recruiting
- NCT06687538 — Effect of Education to be Provided to Patients to Undergo TURP With Mobile Application on Patient Outcomes · NA · recruiting
- NCT07012070 — Improving Walking Performance in Patients With Peripheral Artery Disease Through Wearable Activity Trackers · NA · recruiting
- NCT06442774 — MamaConecta: Digital Tool for Maternal Mental Health · NA · recruiting
Other recruiting trials for Cervix Cancer
Currently open trials in the same condition.
- NCT07276360 — Hypofractionated Radiotherapy for the Treatment of Locally Advanced Cervical Cancer in Uganda · Phase 2 · recruiting
- NCT07292818 — Hyaluronic Acid-based Gel Spacers in Gynecologic Malignancies · Phase 1 · recruiting
- NCT07435623 — Late Radiation Toxicities in Cervical and Endometrial Cancer: A Postoperative IMRT/Brachytherapy Study · recruiting
- NCT06904365 — Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women · recruiting
- NCT06416748 — Minimally Invasive Simple Hysterectomy in Low Risk Cervical Cancer · NA · recruiting
Other Kutahya Health Sciences University trials
Trials by the same sponsor.
- NCT07522658 — Artificial Intelligence-Generated vs Academician-Developed Multiple True/False Questions in Anesthesiology Education · not yet recruiting
- NCT07536685 — THE TURKISH VERSION OF THE EKSTEROCEPTIVE BODY AWARENESS QUESTIONNAIRE · enrolling by invitation
- NCT07501416 — High-Intensity Laser Therapy in Hemiplegic Shoulder Pain · NA · not yet recruiting
- NCT07504887 — Effects of Aerobic Exercise in Rheumatoid Arthritis · NA · not yet recruiting
- NCT07460193 — CBCT and Audiological Analysis of the TMJ-Tinnitus Relationship · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06252012 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Kutahya Health Sciences University
- Last refreshed: 3 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06252012.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing